Table 3 Twenty major groups showing enhanced enrichment
GO | Category | Description | Count | % | Log10 (P) | Log10(q) |
|---|---|---|---|---|---|---|
ko04210 | KEGG pathway | Apoptosis | 51 | 27.87 | −70.51 | −66.23 |
ko04114 | KEGG pathway | Oocyte meiosis | 37 | 20.22 | −47.57 | −43.76 |
ko04110 | KEGG pathway | Cell cycle | 37 | 20.22 | −46.32 | −42.64 |
mmu05161 | KEGG pathway | Hepatitis B | 38 | 20.77 | −44.52 | −41.08 |
WP2902 | WikiPathways | p53 signalling | 28 | 15.30 | −39.87 | −36.63 |
GO:0097190 | GO BP | Apoptotic signalling pathway | 52 | 28.42 | −35.54 | −32.46 |
GO:1903047 | GO BP | Mitotic cell cycle process | 53 | 28.96 | −34.08 | −31.02 |
ko05166 | KEGG pathway | HTLV-I infection | 36 | 19.67 | −30.68 | −27.83 |
GO:0070997 | GO BP | Neuron death | 39 | 21.31 | −27.54 | − 24.82 |
ko04380 | KEGG pathway | Osteoclast differentiation | 26 | 14.21 | −27.41 | −24.69 |
ko04621 | KEGG pathway | NOD-like receptor signalling pathway | 27 | 14.75 | −25.68 | −23.10 |
ko05169 | KEGG pathway | Epstein–Barr virus infection | 29 | 15.85 | −25.22 | −22.66 |
R-MMU-3700989 | Reactome GS | Transcriptional regulation by TP53 | 28 | 15.30 | −20.80 | −18.48 |
WP373 | WikiPathways | IL-3 signalling pathway | 19 | 10.38 | −19.72 | −17.46 |
ko05162 | KEGG pathway | Measles | 21 | 11.48 | −19.68 | −17.43 |
R-MMU-1280218 | Reactome GS | Adaptive immune system | 37 | 20.22 | −19.23 | −17.01 |
GO:0006974 | GO BP | Cellular response to DNA damage stimulus | 39 | 21.31 | −18.33 | −16.14 |
GO:0031329 | GO BP | Regulation of cellular catabolic process | 38 | 20.77 | −17.85 | −15.69 |
R-MMU-5218859 | Reactome GS | Regulated necrosis | 14 | 7.65 | −17.59 | −15.44 |
GO:0018105 | GO BP | Peptidyl-serine phosphorylation | 27 | 14.75 | −17.53 | −15.40 |